Try our beta test site

Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants (LAIF)

This study has been terminated.
(Primary endpoint showed no stat significant difference. FU > M12 terminated.)
Information provided by (Responsible Party):
Swedish Orphan Biovitrum Identifier:
First received: June 8, 2011
Last updated: July 29, 2015
Last verified: July 2015